04:23 PM EST, 12/23/2024 (MT Newswires) -- AVITA Medical ( RCEL ) said Monday that the US Food and Drug Administration has approved its premarket approval supplement for Recell Go Mini.

The Recell Go Mini disposable cartridge, which is a line extension of the Recell Go system, was designed specifically to treat smaller wounds of up to 480 square centimeters, the company said.

AVITA said the rollout will start with trauma and burn centers that treat smaller wounds during Q1 2025.

The shares of AVITA Medical ( RCEL ) rose 4.3% in after-hours trading.